-
1
-
-
84883441321
-
Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients.
-
Julia F, Petrella T, Beylot-Barry M, Bagot M, Lipsker D, Machet L, Joly P, Dereure O, Wetterwald M, d'Incan M, Grange F, Cornillon J, Tertian G, Maubec E, Saiag P, Barete S, Templier I, Aubin F, Dalle S. Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol. 2013; 169, 579-86
-
(2013)
Br J Dermatol
, vol.169
, pp. 579-586
-
-
Julia, F.1
Petrella, T.2
Beylot-Barry, M.3
Bagot, M.4
Lipsker, D.5
Machet, L.6
Joly, P.7
Dereure, O.8
Wetterwald, M.9
d'Incan, M.10
Grange, F.11
Cornillon, J.12
Tertian, G.13
Maubec, E.14
Saiag, P.15
Barete, S.16
Templier, I.17
Aubin, F.18
Dalle, S.19
-
2
-
-
84863040874
-
Blastic plasmacytoid dendritic cell neoplasm
-
Lee JK, Schiller G. Blastic plasmacytoid dendritic cell neoplasm. Clin Adv Hematol Oncol. 2012; 10: 60-2.
-
(2012)
Clin Adv Hematol Oncol.
, vol.10
, pp. 60-62
-
-
Lee, J.K.1
Schiller, G.2
-
3
-
-
84879409907
-
Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation
-
Kharfan-Dabaja MA, Lazarus HM, Nishihori T, Mahfouz RA, Hamadani M. Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2013; 19: 1006-12.
-
(2013)
Biol Blood Marrow Transplant.
, vol.19
, pp. 1006-1012
-
-
Kharfan-Dabaja, M.A.1
Lazarus, H.M.2
Nishihori, T.3
Mahfouz, R.A.4
Hamadani, M.5
-
4
-
-
72749104723
-
Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?
-
Dalle S, Beylot-Barry M, Bagot M, Lipsker D, Machet L, Joly P, Dompmartin A, d'Incan M, Maubec E, Grange F, Dereure O, Prey S, Barete S, Wetterwald M, Fraitag S, Petrella T. Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br J Dermatol, 74-9.
-
Br J Dermatol
, pp. 74-79
-
-
Dalle, S.1
Beylot-Barry, M.2
Bagot, M.3
Lipsker, D.4
Machet, L.5
Joly, P.6
Dompmartin, A.7
d'Incan, M.8
Maubec, E.9
Grange, F.10
Dereure, O.11
Prey, S.12
Barete, S.13
Wetterwald, M.14
Fraitag, S.15
Petrella, T.16
-
5
-
-
79960262495
-
Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity
-
Dietrich S, Andrulis M, Hegenbart U, Schmitt T, Bellos F, Martens UM, Meissner J, Krämer A, Ho AD, Dreger P. Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity. Biol Blood Marrow Transplant. 2011; A17:1250-4
-
(2011)
Biol Blood Marrow Transplant
, vol.A17
, pp. 1250-1254
-
-
Dietrich, S.1
Andrulis, M.2
Hegenbart, U.3
Schmitt, T.4
Bellos, F.5
Martens, U.M.6
Meissner, J.7
Krämer, A.8
Ho, A.D.9
Dreger, P.10
-
6
-
-
0036493344
-
Clinical and biologic features of CD4(+) CD56(+) malignancies
-
Feuillard J, Jacob MC, Valensi F, Maynadié M, Gressin R, Chaperot L, Arnoulet C, Brignole-Baudouin F, Drénou B, Duchayne E, Falkenrodt A, Garand R, Homolle E, Husson B, Kuhlein E, Le Calvez G, Sainty D, Sotto MF, Trimoreau F, Béné MC. Clinical and biologic features of CD4(+) CD56(+) malignancies. Blood. 2002; 99: 1556-63.
-
(2002)
Blood.
, vol.99
, pp. 1556-1563
-
-
Feuillard, J.1
Jacob, M.C.2
Valensi, F.3
Maynadié, M.4
Gressin, R.5
Chaperot, L.6
Arnoulet, C.7
Brignole-Baudouin, F.8
Drénou, B.9
Duchayne, E.10
Falkenrodt, A.11
Garand, R.12
Homolle, E.13
Husson, B.14
Kuhlein, E.15
Le Calvez, G.16
Sainty, D.17
Sotto, M.F.18
Trimoreau, F.19
Béné, M.C.20
more..
-
7
-
-
0141893290
-
What is CD4+CD56+ malignancy and how should it be treated?
-
Reimer P, Rüdiger T, Kraemer D, Kunzmann V, Weissinger F, Zettl A, Müller-Hermelink K, Wilhelm M. What is CD4+CD56+ malignancy and how should it be treated? Bone Marrow Transplant. 2003; 32: 637-46.
-
(2003)
Bone Marrow Transplant.
, vol.32
, pp. 637-646
-
-
Reimer, P.1
Rüdiger, T.2
Kraemer, D.3
Kunzmann, V.4
Weissinger, F.5
Zettl, A.6
Müller-Hermelink, K.7
Wilhelm, M.8
-
8
-
-
84872470209
-
European Group for Blood and Marrow Transplantation Lymphoma, Pediatric Diseases, and Acute Leukemia Working Parties. Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation
-
Roos-Weil D, Dietrich S, Boumendil A, Polge E, Bron D, Carreras E, Iriondo Atienza A, Arcese W, Beelen DW, Cornelissen JJ, Kröger N, Milone G, Rossi G, Jardin F, Peters C, Rocha V, Sureda A, Mohty M, Dreger P; European Group for Blood and Marrow Transplantation Lymphoma, Pediatric Diseases, and Acute Leukemia Working Parties. Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. Blood. 2013; 17;121: 440-6.
-
(2013)
Blood.
, vol.17
, Issue.121
, pp. 440-446
-
-
Roos-Weil, D.1
Dietrich, S.2
Boumendil, A.3
Polge, E.4
Bron, D.5
Carreras, E.6
Iriondo Atienza, A.7
Arcese, W.8
Beelen, D.W.9
Cornelissen, J.J.10
Kröger, N.11
Milone, G.12
Rossi, G.13
Jardin, F.14
Peters, C.15
Rocha, V.16
Sureda, A.17
Mohty, M.18
Dreger, P.19
-
9
-
-
33846441606
-
Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?
-
Garnache-Ottou F, Feuillard J, Saas P. Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity? Br J Haematol. 2007; 136: 539-548.
-
(2007)
Br J Haematol.
, vol.136
, pp. 539-548
-
-
Garnache-Ottou, F.1
Feuillard, J.2
Saas, P.3
-
10
-
-
34249732606
-
(2007) CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells
-
Herling M, Jones D. (2007) CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells. Am J Clin Pathol. 2007; 127: 687-700.
-
(2007)
Am J Clin Pathol.
, vol.127
, pp. 687-700
-
-
Herling, M.1
Jones, D.2
-
11
-
-
0141649429
-
CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells
-
Jacob MC, Chaperot L, Mossuz P, Feuillard J, Valensi F, Leroux D, Béné MC, Bensa JC, Brière F, Plumas J. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica, 2003; 88: 941-55.
-
(2003)
Haematologica
, vol.88
, pp. 941-955
-
-
Jacob, M.C.1
Chaperot, L.2
Mossuz, P.3
Feuillard, J.4
Valensi, F.5
Leroux, D.6
Béné, M.C.7
Bensa, J.C.8
Brière, F.9
Plumas, J.10
-
12
-
-
59449096793
-
Blastic plasmacytoid dendritic cell neoplasms
-
WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues (Swerdlow SH, Campo E, Harris NL, eds) Lyon: IARC
-
Facchetti F JD, Petrella T. (2008) Blastic plasmacytoid dendritic cell neoplasms. In: WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues (Swerdlow SH, Campo E, Harris NL, et al eds) Lyon: IARC; 145-147.
-
(2008)
, pp. 145-147
-
-
Facchetti, F.J.D.1
Petrella, T.2
-
13
-
-
0035874538
-
Identification of a leukemic counterpart of the plasmacytoid dendritic cells
-
Chaperot L, Bendriss N, Manches O, Gressin R, Maynadie M, Trimoreau F, Orfeuvre H, Corront B, Feuillard J, Sotto JJ, Bensa JC, Brière F, Plumas J, Jacob MC. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood. 2001; 97, 3210-7.
-
(2001)
Blood
, vol.97
, pp. 3210-3217
-
-
Chaperot, L.1
Bendriss, N.2
Manches, O.3
Gressin, R.4
Maynadie, M.5
Trimoreau, F.6
Orfeuvre, H.7
Corront, B.8
Feuillard, J.9
Sotto, J.J.10
Bensa, J.C.11
Brière, F.12
Plumas, J.13
Jacob, M.C.14
-
14
-
-
73949122748
-
Plasmacytoid dendritic cells: physiologic roles and pathologic states
-
Jegalian AG, Facchetti F, Jaffe ES. Plasmacytoid dendritic cells: physiologic roles and pathologic states. Adv Anat Pathol. 2009; 16: 392-404.
-
(2009)
Adv Anat Pathol.
, vol.16
, pp. 392-404
-
-
Jegalian, A.G.1
Facchetti, F.2
Jaffe, E.S.3
-
15
-
-
0036301139
-
(2002) 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes
-
Petrella T, Comeau MR, Maynadié M, Couillault G, De Muret A, Maliszewski CR, Dalac S, Durlach A, Galibert L. (2002) 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol. 2002; 26: 852-62.
-
(2002)
Am J Surg Pathol.
, vol.26
, pp. 852-862
-
-
Petrella, T.1
Comeau, M.R.2
Maynadié, M.3
Couillault, G.4
De Muret, A.5
Maliszewski, C.R.6
Dalac, S.7
Durlach, A.8
Galibert, L.9
-
16
-
-
28244492017
-
Plasmacytoid dendritic cells of different origins have distinct characteristics and function: studies of lymphoid progenitors versus myeloid progenitors
-
Yang GX, Lian ZX, Kikuchi K, Moritoki Y, Ansari AA, Liu YJ, Ikehara S, Gershwin ME. Plasmacytoid dendritic cells of different origins have distinct characteristics and function: studies of lymphoid progenitors versus myeloid progenitors. J Immunol. 2005; 175: 7281-7.
-
(2005)
J Immunol.
, vol.175
, pp. 7281-7287
-
-
Yang, G.X.1
Lian, Z.X.2
Kikuchi, K.3
Moritoki, Y.4
Ansari, A.A.5
Liu, Y.J.6
Ikehara, S.7
Gershwin, M.E.8
-
17
-
-
17844395979
-
Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review
-
Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M, Meijer CJ, Courville P, Joly P, Grange F, De Muret A, Machet L, Dompmartin A, Bosq J, Durlach A, Bernard P, Dalac S, Dechelotte P, D'Incan M, Wechsler J, Teitell MA. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol. 2005; 123: 662-75.
-
(2005)
Am J Clin Pathol.
, vol.123
, pp. 662-675
-
-
Petrella, T.1
Bagot, M.2
Willemze, R.3
Beylot-Barry, M.4
Vergier, B.5
Delaunay, M.6
Meijer, C.J.7
Courville, P.8
Joly, P.9
Grange, F.10
De Muret, A.11
Machet, L.12
Dompmartin, A.13
Bosq, J.14
Durlach, A.15
Bernard, P.16
Dalac, S.17
Dechelotte, P.18
D'Incan, M.19
Wechsler, J.20
Teitell, M.A.21
more..
-
18
-
-
79954424656
-
TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm
-
Jardin F, Ruminy P, Parmentier F, Troussard X, Vaida I, Stamatoullas A, Leprêtre S, Penther D, Duval AB, Picquenot JM, Courville P, Capiod JC, Tilly H, Bastard C, Marolleau JP. TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm. Br J Haematol. 2011; 153: 413-6.
-
(2011)
Br J Haematol.
, vol.153
, pp. 413-416
-
-
Jardin, F.1
Ruminy, P.2
Parmentier, F.3
Troussard, X.4
Vaida, I.5
Stamatoullas, A.6
Leprêtre, S.7
Penther, D.8
Duval, A.B.9
Picquenot, J.M.10
Courville, P.11
Capiod, J.C.12
Tilly, H.13
Bastard, C.14
Marolleau, J.P.15
-
19
-
-
80055089066
-
Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion
-
Lucioni M, Novara F, Fiandrino G, Riboni R, Fanoni D, Arra M, Venegoni L, Nicola M, Dallera E, Arcaini L, Onida F, Vezzoli P, Travaglino E, Boveri E, Zuffardi O, Paulli M, Berti E. Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion. Blood. 2011; 118: 4591-4.
-
(2011)
Blood.
, vol.118
, pp. 4591-4594
-
-
Lucioni, M.1
Novara, F.2
Fiandrino, G.3
Riboni, R.4
Fanoni, D.5
Arra, M.6
Venegoni, L.7
Nicola, M.8
Dallera, E.9
Arcaini, L.10
Onida, F.11
Vezzoli, P.12
Travaglino, E.13
Boveri, E.14
Zuffardi, O.15
Paulli, M.16
Berti, E.17
-
20
-
-
84863187754
-
Loss of genomic DNA copy numbers in the p18, p16, p27 and RB loci in blastic plasmacytoid dendritic cell neoplasm.
-
Oiso N, Tatsumi Y, Arao T, Rai S, Kimura M, Nakamura S, Itoh T, Nishio K, Matsumura I, Kawada A. Loss of genomic DNA copy numbers in the p18, p16, p27 and RB loci in blastic plasmacytoid dendritic cell neoplasm. Eur J Dermatol. 2012; 22, 393-4.
-
(2012)
Eur J Dermatol
, vol.22
, pp. 393-394
-
-
Oiso, N.1
Tatsumi, Y.2
Arao, T.3
Rai, S.4
Kimura, M.5
Nakamura, S.6
Itoh, T.7
Nishio, K.8
Matsumura, I.9
Kawada, A.10
-
21
-
-
77949531452
-
Alterations of the cell cycle inhibitors p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms
-
Wiesner T, Obenauf AC, Cota C, Fried I, Speicher MR, Cerroni L. Alterations of the cell cycle inhibitors p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms. J Invest Dermatol. 2009; 130: 1152-1157.
-
(2009)
J Invest Dermatol.
, vol.130
, pp. 1152-1157
-
-
Wiesner, T.1
Obenauf, A.C.2
Cota, C.3
Fried, I.4
Speicher, M.R.5
Cerroni, L.6
-
22
-
-
84898037439
-
Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm.
-
Sep 27. doi: 10.1038/leu.2013.283. [Epub ahead of print]
-
Menezes J, Acquadro F, Wiseman M, Gómez-López G, Salgado RN, Talavera-Casañas JG, Buño I, Cervera JV, Montes-Moreno S, Hernández-Rivas JM, Ayala R, Calasanz MJ, Larrayoz MJ, Brichs LF, Gonzalez-Vicent M, Pisano DG, Piris MA, Alvarez S, Cigudosa JC. Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm. Leukemia. 2013 Sep 27. doi: 10.1038/leu.2013.283. [Epub ahead of print]
-
(2013)
Leukemia
-
-
Menezes, J.1
Acquadro, F.2
Wiseman, M.3
Gómez-López, G.4
Salgado, R.N.5
Talavera-Casañas, J.G.6
Buño, I.7
Cervera, J.V.8
Montes-Moreno, S.9
Hernández-Rivas, J.M.10
Ayala, R.11
Calasanz, M.J.12
Larrayoz, M.J.13
Brichs, L.F.14
Gonzalez-Vicent, M.15
Pisano, D.G.16
Piris, M.A.17
Alvarez, S.18
Cigudosa, J.C.19
-
23
-
-
84886052163
-
Molecular diagnostic profiling of lung cancer specimens with a semiconductorbased massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing
-
Endris V, Penzel R, Warth A, Muckenhuber A, Schirmacher P, Stenzinger A, Weichert W. Molecular diagnostic profiling of lung cancer specimens with a semiconductorbased massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing. J Mol Diagn. 2013; 15, 765-75.
-
(2013)
J Mol Diagn
, vol.15
, pp. 765-775
-
-
Endris, V.1
Penzel, R.2
Warth, A.3
Muckenhuber, A.4
Schirmacher, P.5
Stenzinger, A.6
Weichert, W.7
-
24
-
-
84867301515
-
Predicting the Functional Effect of Amino Acid Substitutions and Indels
-
Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the Functional Effect of Amino Acid Substitutions and Indels. PLoS ONE. 2012; 7: e46688.
-
(2012)
PLoS ONE.
, vol.7
-
-
Choi, Y.1
Sims, G.E.2
Murphy, S.3
Miller, J.R.4
Chan, A.P.5
-
25
-
-
68149165614
-
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
-
Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc, 2009; 4: 1073-81.
-
(2009)
Nat Protoc
, vol.4
, pp. 1073-1081
-
-
Kumar, P.1
Henikoff, S.2
Ng, P.C.3
-
26
-
-
77955151784
-
MutationTaster evaluates disease-causing potential of sequence alterations
-
Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2012; 7:575-6.
-
(2012)
Nat Methods.
, vol.7
, pp. 575-576
-
-
Schwarz, J.M.1
Rödelsperger, C.2
Schuelke, M.3
Seelow, D.4
-
27
-
-
0036713510
-
Human non-synonymous SNPs: server and survey
-
Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res, 2002; 30: 3894-900.
-
(2002)
Nucleic Acids Res
, vol.30
, pp. 3894-3900
-
-
Ramensky, V.1
Bork, P.2
Sunyaev, S.3
-
28
-
-
64849117150
-
Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease
-
Jardin F, Callanan M, Penther D, Ruminy P, Troussard X, Kerckaert JP, Figeac M, Parmentier F, Rainville V, Vaida I, Bertrand P, Duval AB, Picquenot JM, Chaperot L, Marolleau JP, Plumas J, Tilly H, Bastard C. Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease. Leukemia. 2009; 23: 698-707.
-
(2009)
Leukemia.
, vol.23
, pp. 698-707
-
-
Jardin, F.1
Callanan, M.2
Penther, D.3
Ruminy, P.4
Troussard, X.5
Kerckaert, J.P.6
Figeac, M.7
Parmentier, F.8
Rainville, V.9
Vaida, I.10
Bertrand, P.11
Duval, A.B.12
Picquenot, J.M.13
Chaperot, L.14
Marolleau, J.P.15
Plumas, J.16
Tilly, H.17
Bastard, C.18
-
29
-
-
84888061596
-
TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow.
-
in press. doi: 10.1002/ajh.23567
-
Alayed K, Patel KP, Konoplev S, Singh RR, Routbort MJ, Reddy N, Pemmaraju N, Zhang L, Shaikh AA, Aladily TN, Jain N, Luthra R, Jeffrey Medeiros L, Khoury JD. TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow. Am J Hematol. 2013 in press. doi: 10.1002/ajh.23567
-
(2013)
Am J Hematol
-
-
Alayed, K.1
Patel, K.P.2
Konoplev, S.3
Singh, R.R.4
Routbort, M.J.5
Reddy, N.6
Pemmaraju, N.7
Zhang, L.8
Shaikh, A.A.9
Aladily, T.N.10
Jain, N.11
Luthra, R.12
Jeffrey Medeiros, L.13
Khoury, J.D.14
-
30
-
-
84891083559
-
The biology and clinical impact of genetic lesions in myeloid malignancies
-
Lindsley RC, Ebert BL. The biology and clinical impact of genetic lesions in myeloid malignancies. Blood. 2013; 122: 3741-8.
-
(2013)
Blood.
, vol.122
, pp. 3741-3748
-
-
Lindsley, R.C.1
Ebert, B.L.2
-
31
-
-
84880450809
-
Leveraging cancer genome information in hematologic malignancies
-
Rampal R, Levine RL. Leveraging cancer genome information in hematologic malignancies. J Clin Oncol. 2013; 31: 1885-92.
-
(2013)
J Clin Oncol.
, vol.31
, pp. 1885-1892
-
-
Rampal, R.1
Levine, R.L.2
-
32
-
-
6844258870
-
ATM is usually rearranged in T-cellprolymphocytic leukaemia
-
Yuille MA, Coignet LJ, Abraham SM, Yaqub F, Luo L, Matutes E, Brito-Babapulle V, Vorechovskỳ I, Dyer MJ, Catovsky D. ATM is usually rearranged in T-cellprolymphocytic leukaemia. Oncogene. 1998; 16: 789-96.
-
(1998)
Oncogene.
, vol.16
, pp. 789-796
-
-
Yuille, M.A.1
Coignet, L.J.2
Abraham, S.M.3
Yaqub, F.4
Luo, L.5
Matutes, E.6
Brito-Babapulle, V.7
Vorechovskỳ, I.8
Dyer, M.J.9
Catovsky, D.10
-
33
-
-
0034646371
-
Mantle cell lymphoma is characterized by inactivation of the ATM gene.
-
Schaffner C, Idler I, Stilgenbauer S, Dohner H, Lichter P. Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci U S A. 2007; 97, 2773-2778.
-
(2007)
Proc Natl Acad Sci U S A
, vol.97
, pp. 2773-2778
-
-
Schaffner, C.1
Idler, I.2
Stilgenbauer, S.3
Dohner, H.4
Lichter, P.5
-
34
-
-
0037103190
-
ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma
-
Grønbaek K, Worm J, Ralfkiaer E, Ahrenkiel V, Hokland P, Guldberg P. ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma. Blood. 2002; 100: 1430-7
-
(2002)
Blood
, vol.100
, pp. 1430-1437
-
-
Grønbaek, K.1
Worm, J.2
Ralfkiaer, E.3
Ahrenkiel, V.4
Hokland, P.5
Guldberg, P.6
-
35
-
-
0033513587
-
Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia
-
Stankovic T, Weber P, Stewart G, Bedenham T, Murray J, Byrd PJ, Moss PA, Taylor AM. (1999) Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet. 1999; 353, 26-9.
-
(1999)
Lancet. 1999
, vol.353
, pp. 26-29
-
-
Stankovic, T.1
Weber, P.2
Stewart, G.3
Bedenham, T.4
Murray, J.5
Byrd, P.J.6
Moss, P.A.7
Taylor, A.M.8
-
36
-
-
16544377649
-
Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection.
-
Zuniga EI, McGavern DB, Pruneda-Paz JL, Teng C, Oldstone MB. Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection. Nat Immunol. 2004; 5: 1227-1234
-
(2004)
Nat Immunol.
, vol.5
, pp. 1227-1234
-
-
Zuniga, E.I.1
McGavern, D.B.2
Pruneda-Paz, J.L.3
Teng, C.4
Oldstone, M.B.5
-
37
-
-
84905519085
-
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-KB pathway inhibition.
-
2014 Feb 7. doi: 10.1038/leu.2014.64. [Epub ahead of print]
-
Sapienza MR, Fuligni F, Agostinelli C, Tripodo C, Righi S, Laginestra MA, Pileri A, Mancini M, Rossi M, Ricci F, Gazzola A, Melle F, Mannu C, Ulbar F, Arpinati M, Paulli M, Maeda T, Gibellini D, Pagano L, Pimpinelli N, Santucci M, Cerroni L, Croce CM, Facchetti F, Piccaluga PP, Pileri SA. (2014) Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-KB pathway inhibition. Leukemia. 2014 Feb 7. doi: 10.1038/leu.2014.64. [Epub ahead of print]
-
(2014)
Leukemia
-
-
Sapienza, M.R.1
Fuligni, F.2
Agostinelli, C.3
Tripodo, C.4
Righi, S.5
Laginestra, M.A.6
Pileri, A.7
Mancini, M.8
Rossi, M.9
Ricci, F.10
Gazzola, A.11
Melle, F.12
Mannu, C.13
Ulbar, F.14
Arpinati, M.15
Paulli, M.16
Maeda, T.17
Gibellini, D.18
Pagano, L.19
Pimpinelli, N.20
Santucci, M.21
Cerroni, L.22
Croce, C.M.23
Facchetti, F.24
Piccaluga, P.P.25
Pileri, S.A.26
more..
-
38
-
-
77049102382
-
Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group
-
Tsagarakis NJ, Kentrou NA, Papadimitriou KA, Pagoni M, Kokkini G, Papadaki H, Pappa V, Marinakis T, Anagnostopoulos NI, Vadikolia C, Anagnostopoulos A, Angelopoulou MK, Terpos E, Poziopoulos C, Anargyrou K, Rontogianni D, Papadaki T, Psarra A, Kontopidou FN, Skoumi D, Papadhimitriou SI, Paterakis G; Hellenic Dendritic Cell Leukemia Study Group. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group. Leuk Res. 2010; 34:438-46.
-
(2010)
Leuk Res.
, vol.34
, pp. 438-446
-
-
Tsagarakis, N.J.1
Kentrou, N.A.2
Papadimitriou, K.A.3
Pagoni, M.4
Kokkini, G.5
Papadaki, H.6
Pappa, V.7
Marinakis, T.8
Anagnostopoulos, N.I.9
Vadikolia, C.10
Anagnostopoulos, A.11
Angelopoulou, M.K.12
Terpos, E.13
Poziopoulos, C.14
Anargyrou, K.15
Rontogianni, D.16
Papadaki, T.17
Psarra, A.18
Kontopidou, F.N.19
Skoumi, D.20
Papadhimitriou, S.I.21
Paterakis G22
Hellenic Dendritic Cell Leukemia Study, Group.23
more..
-
39
-
-
78149247393
-
Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications
-
Jegalian AG, Buxbaum NP, Facchetti F, Raffeld M, Pittaluga S, Wayne AS, Jaffe ES. Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica. 2010; 95: 1873-9.
-
(2010)
Haematologica.
, vol.95
, pp. 1873-1879
-
-
Jegalian, A.G.1
Buxbaum, N.P.2
Facchetti, F.3
Raffeld, M.4
Pittaluga, S.5
Wayne, A.S.6
Jaffe, E.S.7
-
40
-
-
84868569000
-
Targeting oncogenic Ras signaling in hematologic malignancies
-
Ward AF, Braun BS, Shannon KM. Targeting oncogenic Ras signaling in hematologic malignancies. Blood. 2012; 120: 3397-406.
-
(2012)
Blood.
, vol.120
, pp. 3397-3406
-
-
Ward, A.F.1
Braun, B.S.2
Shannon, K.M.3
-
41
-
-
84862726767
-
ERK inhibition overcomes acquired resistance to MEK inhibitors
-
Hatzivassiliou G, Liu B, O'Brien C, Spoerke JM, Hoeflich KP, Haverty PM, Soriano R, Forrest WF, Heldens S, Chen H, Toy K, Ha C, Zhou W, Song K, Friedman LS, Amler LC, Hampton GM, Moffat J, Belvin M, Lackner MR. ERK inhibition overcomes acquired resistance to MEK inhibitors. Mol Cancer Ther. 2012; 11:1143-54.
-
(2012)
Mol Cancer Ther.
, vol.11
, pp. 1143-1154
-
-
Hatzivassiliou, G.1
Liu, B.2
O'Brien, C.3
Spoerke, J.M.4
Hoeflich, K.P.5
Haverty, P.M.6
Soriano, R.7
Forrest, W.F.8
Heldens, S.9
Chen, H.10
Toy, K.11
Ha, C.12
Zhou, W.13
Song, K.14
Friedman, L.S.15
Amler, L.C.16
Hampton, G.M.17
Moffat, J.18
Belvin, M.19
Lackner, M.R.20
more..
-
42
-
-
34248591612
-
Targeting the Raf-MEK-ERK mitogenactivated protein kinase cascade for the treatment of cance
-
Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogenactivated protein kinase cascade for the treatment of cance. Oncogene. 2007; 26:3291-310.
-
(2007)
Oncogene.
, vol.26
, pp. 3291-3310
-
-
Roberts, P.J.1
Der, C.J.2
|